Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

10-methoxy-9-nitrocamptothecin

Known as: MONCPT cpd 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
PurposeIn previous research, we found that 10-methoxy-9-nitrocamptothecin (MONCPT) possessed potent anti-tumor activity in A549… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2009
2009
PURPOSE The potent anti-cancer capability of a novel CPT derivarate, 10-methoxy-9-nitrocamptothecin (MONCPT), has been… Expand
Is this relevant?
2008
2008
PurposeAn oil/water nanoemulsion was developed in the present study to enhance the solubility, stability and anti-tumor activity… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2006
2006
10-Methoxy-9-nitrocamptothecin (MONCPT), a topoisomerase I inhibitor, exhibited high anticancer activity in solid tumour… Expand
Is this relevant?
2006
2006
The present data showed that 10-methoxy-9-nitrocamptothecin (MONCPT), a family of camptothecin analogues, possessed high… Expand
  • table 1
  • figure 2
  • table 2
  • figure 3
  • table 3
Is this relevant?